Table 2.
In entire study population, factors associating with 30-day mortality after hospital arrival.
Variable | Mortality (%) | Crude OR (95%CI) | Adjusted OR (95%CI) | P-value |
---|---|---|---|---|
Age—yr | 1.029 (1.002–1.057) | 1.037 (0.998–1.078) | 0.065 | |
Sex | ||||
Female | 25/97 (25.8) | (Reference) | (Reference) | |
Male | 37/143 (25.9) | 1.005 (0.558–1.812) | 1.341 (0.617–2.916) | 0.459 |
SBP on ED arrival | 0.990 (0.980–0.999) | 0.990 (0.977–1.004) | 0.164 | |
HR on ED arrival | 1.001 (0.994–1.009) | 1.003 (0.993–1.013) | 0.570 | |
RR on ED arrival | 0.968 (0.937–0.999) | 0.979 (0.940–1.020) | 0.318 | |
The pathophysiology of shock* | ||||
Non—pump | 22/113 (19.5) | (Reference) | (Reference) | |
Pump | 40/127 (31.5) | 1.902 (1.046–3.457) | 2.278 (1.062–4.888) | 0.035 |
eGFR | ||||
G0/1/2 | 6/46 (13.0) | (Reference) | (Reference) | |
G3a | 7/57 (12.3) | 0.933 (0.291–2.998) | 0.966 (0.255–3.657) | 0.959 |
G3b | 24/72 (33.3) | 3.333 (1.241–8.954) | 2.463 (0.756–8.032) | 0.135 |
G4/5 | 24/62 (38.7) | 4.211 (1.551–11.43) | 3.748 (1.148–12.24) | 0.029 |
Administration of vasopressor agents | ||||
Norepinephrine | 26/98 (26.5) | (Reference) | (Reference) | |
Dopamine | 36/142 (25.4) | 0.940 (0.523–1.691) | 1.003 (0.480–2.094) | 0.994 |
the pathophysiology of shock consisted of pump and non-pump including volume and rate. OR, odds ratio; CI, confidence interval; SBP, systolic blood pressure; ED, emergency department; HR, heart rate; eGFR, estimated glomerular filtration rate.